Appointment of Mr. Ritik Pavecha (DIN: 08790431) as an Additional Director in the category of Non Executive Independent Director of the company w.e.f. 07.02.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Choksi Laboratories Ltd has appointed Mr. Ritik Pavecha (DIN: 08790431) as an Additional Director in the Non-Executive Independent Director category, effective 7th February 2026, for a term of five years pending shareholder approval. Mr. Pavecha is a corporate professional with Big Four audit experience and Company Secretary expertise, specializing in audit, assurance, corporate compliance, governance, and regulatory advisory. He is not related to any existing director, KMP, or promoter of the company, holds no equity shares in it, and is not debarred by SEBI or any other authority from holding a directorship.
This is a routine board-level appointment that strengthens the company's independent oversight and governance framework. It is unlikely to have any material impact on the stock price, though it reflects compliance with board composition norms under SEBI LODR regulations.